Antifungal activity of organotin compounds with functionalized carboxylates evaluated by the microdilution bioassay in vitro

References

• Odds FC, Brown AJP, Gow NAR. Antifungal agents: mechanisms of action. Trends Microbiol 2003; 11: 272–279.
   PubMed Web of Science ®Google Scholar
• Gupta AK, Sauder DN, Shear NH. Antifungal agents: an overview. Part I. J Am Acad Dermatol 1994; 30: 677–698.
   PubMed Web of Science ®Google Scholar
• Espinel-Ingroff A. In vitro antifungal activities of anidulafungin and micafungin, licensed agents and the investigational triazole posaconazole as determined by NCCLS methods for 12,052 fungal isolates: review of the literature. Rev Iberoam Micol 2003; 20: 121–136.
   PubMedGoogle Scholar
• Arathoon EG. Clinical efficacy of echinocandin antifungals. Curr Opin Infect Dis 2001; 14: 685–691.
   PubMed Web of Science ®Google Scholar
• Magil SS, Shields C, Sears CL, Choti M, Merz WG. Triazole cross-resistance among Candida spp: case report, occurrence among bloodstream isolates and implications for antifungal therapy. J Clin Microbiol 2006; 44: 529–535.
   PubMedGoogle Scholar
• Sanguinetti M, Posteraro B, Fiori B, . Mechanism of azole resistance in clinical isolates of Candida glabrata collected during a hospital survey of antifungal resistance. Antimicrob Agents Chem 2005; 49: 668–679.
   PubMed Web of Science ®Google Scholar
• Orozco AS, Higginbotham LM, Hitchcock CA, . Mechanism of fluconazole resistance in Candida krusei. Antimicrob Agents Chem 1998; 42: 2645–2649.
   PubMed Web of Science ®Google Scholar
• Vazquez JA. Anidulafungin: a new echinocandin with a novel profile. Clin Ther 2005; 27: 657–673.
   PubMed Web of Science ®Google Scholar
• Denning DW. Echinocandin antifungal drugs. Lancet 2003; 362: 1142–1151.
   PubMed Web of Science ®Google Scholar
• Boucher HW, Groll AH, Chiou CC, . Newer systemic antifungal agents, pharmacokinetics, safety and efficacy. Drugs 2004; 64: 1997–2020.
   PubMed Web of Science ®Google Scholar
• Gupta AK, Sauder DN, Shear NH. Antifungal agents: an overview. Part II. J Am Acad Dermatol 1994; 30: 911–933.
   PubMed Web of Science ®Google Scholar
• Smith PJ. Chemistry of Tin, 2nd London: Blackie Academic & Professional, 1997.
   Google Scholar
• Davies AG. Tin. Abel EW, Stone FGA, Wilkinson G. Comprehensive Organometallic Chemistry, 2nd. Oxford: Pergamon Press, 1995: 217–303..
   Google Scholar
• Crowe AJ. The antitumour activity of tin compounds. Gielen M. Metal-Based Antitumour Drugs. Tel Aviv: Freund, 1989: 103–149.
   Google Scholar
• Pruchnik FP, Bańbula M, Ciunik Z, . Di-n-butyltin aminoarylcarboxylates: structure, properties and in vitro antitumor activity. Appl Organomet Chem 2002; 16: 587–592.
   Web of Science ®Google Scholar
• Pruchnik FP, Banbula M, Ciunik Z, . Structure, properties and cytostatic activity of triorganotin (Aminoaryl)carboxylates. Eur J Inorg Chem 2002; 135: 3214–3221.
   Google Scholar
• Pruchnik FP, Banbula M, Ciunik Z, . Structure, properties and cytostatic activity of tributyltin aminocarboxylates. Inorg Chim Acta 2003; 356: 62–68.
   Web of Science ®Google Scholar
• Gielen M, Tiekink ERT. Tin compounds and their therapeutic potential. Gielen M, Tiekink ERT Metallotherapeutic Drugs and Metal-based Diagnostic Agents: The Use of Metals in Medicine 1st. Chichester: John Wiley& Sons, 2005: 421–439.
   Google Scholar
• Hadjikakou SK, Hadjiliadis N. Antiproliferative and anti-tumor activity of organotin compounds. Coordin Chem Rev 2009; 253: 235–249.
   Web of Science ®Google Scholar
• Bonire JJ, Ayoko GA, Olurinola PF, . Synthesis and antifungal activity of some organotin carboxylates. Metal-Based Drugs 1998; 5: 233–236.
   PubMedGoogle Scholar
• Mishra AK, Manav N, Kaushik AK. Organotin (IV) complexes of thiohydrazones: synthesis, characterization and antifungal study. Spectrochim Acta A 2005; 61: 3097–3101.
   PubMed Web of Science ®Google Scholar
• Singh HL, Varshney AK. Synthetic, structural, and biochemical studies of organotin (IV) with Schiff Bases having nitrogen and sulphur donor ligands. Bioinorg Chem Appl 2006; 2006: 1–7.
   Google Scholar
• Nath M, Sulaxna , Song X, Eng G, Kumar A. Synthesis and spectral studies of organotin (IV)4-amino-3-alkyl-1,2,4-triazole-5-thionates:In vitro antimicrobial activity. Spectrochim Acta A 2008; 70: 766–774.
   PubMed Web of Science ®Google Scholar
• Gielen M. Organotin compounds and their therapeutic potential: a report from the Organometallic Chemistry Department of Free University of Brussels. Appl Organomet Chem 2002; 16: 481–494.
   Web of Science ®Google Scholar
• Pruchnik FP, Pruchnik H, Dylag M, Ulaszewski S. New organotin compounds about cytostatic properties and the way of production new organotin compounds about cytostatic properties. The Patent Notification no. P.385165. Date of application for a patent: 12 May 2008, Patent Office of the Republic of Poland.
   Google Scholar
• McGinnis MR. Laboratory Handbook of Medical Mycology. New York: Academic Press, 1980.
   Google Scholar
• National Committee for Clinical Laboratory Standards. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeast 2nd. Approved Standard M27-A2. Wayne, PA: National Committee for Clinical Laboratory Standards, 2002.
   Google Scholar
• Mycology Online. The University of Adelaide, Australia: Antifungal Susceptibility Testing; [updated 28 November 2008 by Dr D. Ellis; cited 2 July 2008] Available from: http://www.mycology.adelaide.edu.au/Laboratory_Methods/Antifungal_Susceptibility_ Testing/overview.html>
   Google Scholar
• National Committee for Clinical Laboratory Standards. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Filamentous Fungi. Approved Standard M38 –A. Wayne, PA: National Committee for Clinical Laboratory Standards, 2002.
   Google Scholar
• National Committee for Clinical Laboratory Standards. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Conidium Forming Filamentous Fungi; proposed standard. NCCLS document M38-P. Wayne, PA: National Committee for Clinical Laboratory Standards, 1998.
   Google Scholar
• Nadvornik M, Holeček J, Handlir K, Lycka A. The 13C and 119Sn NMR spectra of some four and five-coordinate tri-n-butyltin (IV) compounds. J Organomet Chem 1984; 275: 43–51.
   Web of Science ®Google Scholar
• Wrackmeyer B. Application of 119Sn NMR parameters. Ann R NMR S 1999; 38: 203–264.
   Web of Science ®Google Scholar
• Webster TD, Dickson RC. Direct selection of Saccharomyces cerevisiae resistant to the antibiotic G418 following transformation with a DNA vector carrying the kanamycin resistance gene of Tn903. Gene 1983; 26: 243–252.
   PubMed Web of Science ®Google Scholar
• Fernández-Torres B, Cabañes FJ, Carrillo-Muñoz AJ, . Collaborative evaluation of optimal antifungal susceptibility testing conditions for dermatophytes. J Clin Microbiol 2002; 40: 3999–4003.
   PubMed Web of Science ®Google Scholar
• National Committee for Clinical Laboratory Standards. Performance Standard for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated from Animals. Approved Standard M31-A. Wayne, PA: National Committee for Clinical Laboratory Standards, 1999.
   Google Scholar
• Becker JM, Caldwell GA, Zachgo EA. Biotechnology: A Laboratory Course, 2nd. New York: Academic Press, 1996.
   Google Scholar
• Singh J, Zaman M, Gupta KA. Evaluation of microdilution and disk diffusion methods for antifungal susceptibility testing of dermatophytes. Med Mycol 2007; 45: 595–602.
   PubMed Web of Science ®Google Scholar
• Carillo-Muñoz AJ, Giusiano G, Guarro J, . In vitro activity of voriconazole against dermatophytes, Scopulariopsis brevicaulis, and other opportunistic fungi as agents of onychomycosis. Int J Antimicrob Ag 2007; 30: 157–161.
   PubMedGoogle Scholar
• National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing for yeasts. Proposed standard M27-P. National Committee for Clinical Laboratory Standards, Villanova, PA, 1992.
   Google Scholar
• Espinel-Ingroff A, Walsh TJ, Fothergill A, . Testing conditions for determination of Minimum Fungicidal Concentrations of new and established antifungal agents for Aspergillus spp. NCCLS collaborative study. J Clin Microbiol 2002; 40: 3204–3208.
   PubMed Web of Science ®Google Scholar
• Skehan P, Storeng R, Scudiero D, . New colorymetric cytotoxity assay for anticancer-drug screening. J Natl Cancer Inst 1990; 82: 1107–1112.
   PubMed Web of Science ®Google Scholar
• Cuenca-Estrella M, Gomez-Lopez A, Mellado E, . Scopulariopsis brevicaulis, a fungal pathogen resistant to broad-spectrum antifungal agents. Antimicrob Agents Chemo 2003; 47: 2339–2341.
   PubMed Web of Science ®Google Scholar
• Cuenca-Estrella M, Gomez-Lopez A, Buitrago MJ, . In vitro activities of 10 combinations of antifungal agents against the multiresistant pathogen Scopulariopsis brevicaulis. Antimicrob Agents Ch 2006; 50: 2248–2250.
   PubMed Web of Science ®Google Scholar
• Skarning CR-F, Varhaug LN, Fonnum F, . Effects of in vivo treatment of rats with trimethyltin chloride on respiratory properties of rat liver mitochondria. Biochem Pharmacol 2002; 64: 657–667.
   PubMedGoogle Scholar
• Bragadin M, Marton D. A proposal for a new mechanism of interaction of trialkyltin (TAT) compounds with mitochondria. J Inorg Biochem 1997; 68: 75–78.
   Google Scholar
• Nopp A, Lundahl J, Stridh H. Caspase activation in the absence of mitochondrial changes in granulocyte apoptosis. Clin Exp Immunol 2002; 128: 267–274.
   PubMedGoogle Scholar
• Tiano L, Fedeli D, Moretti M, . DNA damage induced by organotins on trout-nucleated erythrocytes. Appl Organomet Chem 2001; 15: 575–580.
   Web of Science ®Google Scholar
• Ballmoos C, Brunner J, Dimroth P. The ion channel of F-ATP synthase is the target of toxic organotin compounds. Proc Natl Acad Sci USA 2004; 101: 11239–11244.
   PubMedGoogle Scholar
• Shi G, Chen D, Zhai G, . The proteasome is a molecular target of environmental toxic organotins. Environ Health Persp 2009; 117: 379–386.
   PubMedGoogle Scholar